Quest Diagnostics did "good enough" against an "increasingly high bar," an analyst said Thursday. But Quest stock fell moderately. The post Why Quest's 'Good Enough' Third Quarter Wasn't Actually Enough appeared first on Investor's Business Daily.
CryptoAlerta — análise de criptomoedas e mercado em tempo real